Parkinson’s Disease

Research Article

Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson’s Disease

Table 2

Clinical features of Parkinson’s disease (PD) patients.
 PD patients ()
Length of illness in years [mean ± SD (range)]5.45 ± 4.13 (0.4–18)
UPDRS [mean ± SD (range)]51.82 ± 25.27 (11–105)
 UPDRS I [mean ± SD (range)]3.36 ± 2.96 (0–11)
 UPDRS II [mean ± SD (range)]14.08 ± 7.14 (2–31)
 UPDRS III [mean ± SD (range)]34.56 ± 18.43 (8–69)
HY [mean ± SD (range)]2.44 ± 0.69 (1–4)
S&E in % [mean ± SD (range)]77.95 ± 11.96 (50–100)
Medications in use [frequency (%)] 
 Levodopa 37 (92.50)
 Pramipexole20 (50.00)
 Entacapone7 (17.50)
 Amantadine11 (27.50)
HY: Hoehn and Yahr staging scale; PD: Parkinson’s disease; SD: standard deviation; S & E: Schwab and England activities of daily living scale; UPDRS: Unified Parkinson’s Disease Rating Scale.